Article

Vitiligo associated with other autoimmune diseases: polyglandular autoimmune syndrome types 3B+C and 4.

Department of Dermatology, University of Chieti-Pescara, Italy.
Clinical and Experimental Dermatology (Impact Factor: 1.23). 10/2006; 31(5):746-9. DOI: 10.1111/j.1365-2230.2006.02171.x
Source: PubMed

ABSTRACT Vitiligo is a common skin disease characterized by depigmented maculae resulting from a reduction of the number and function of melanocytes. Many studies suggest that vitiligo might be an autoimmune disease. Vitiligo has been frequently described in association with other autoimmune diseases. Among the diseases described in association with vitiligo are the so-called autoimmune polyglandular syndromes (APS). Vitiligo can be present in all types of APS but the most frequent association appears to be in APS-3. APS-3 was defined as the association between autoimmune thyroiditis and another autoimmune disease. Here we report one patient with thyroiditis, vitiligo and autoimmune gastritis (APS-3B+C), one patient with chronic autoimmune thyroiditis, vitiligo and alopecia (APS-3C), and one case of a young patient with type 1 diabetes mellitus and vitiligo (APS-4), according to the newest classification. We stress the importance of a thorough assessment for autoimmune diseases in selected patients with vitiligo.

0 Bookmarks
 · 
80 Views
  • [Show abstract] [Hide abstract]
    ABSTRACT: ZusammenfassungDiabetes mellitus ist eine der häufigsten Erkrankungen der westlichen Industrienationen mit weltweit circa 300 Millionen Betroffenen. Die diabetische Stoffwechsellage führt zu Veränderungen praktisch aller Zelltypen und Organe des Körpers. Komplikationen an der Haut zählen hierbei zu den häufigsten Veränderungen. Da Hauterscheinungen einem Diabetes mellitus vorangehen können, besitzen sie eine diagnostische Relevanz. Andere Hautveränderungen und -erkrankungen entwickeln sich erst im Laufe eines Diabetes mellitus, sind mitunter mit Komplikationen innerer Organe assoziiert oder treten als unerwünschte Wirkung einer antidiabetischen Therapie auf. Besonders das Auftreten eines diabetischen Fußsyndroms geht mit einer signifikant erhöhten Morbidität und Mortalität von Diabetes-Patienten einher und führt zu einem bedeutsamen Anstieg direkter und indirekter Kosten im Gesundheitssystem. In diesem Übersichtsartikel werden die häufigsten Hauterkrankungen bei Diabetes mellitus sowie deren Pathophysiologie und aktuelle Therapie dargestellt.
    Journal der Deutschen Dermatologischen Gesellschaft 10/2014; 12(10). · 1.40 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Diabetes mellitus is one of the most common diseases in industrialized Western countries with about 300 million affected patients worldwide. The hyperglycemic state of diabetes mellitus leads to changes in almost every human cell type and organ. Skin changes are considered the most common manifestations of diabetes mellitus. As skin changes can manifest before onset of diabetes mellitus, they may have a diagnostic relevance. Other cutaneous manifestations develop during the course of diabetes mellitus and may be associated with complications in internal organs or may occur as an adverse effect of antidiabetic therapy. In particular, the presence of the diabetic foot syndrome is associated with significantly increased morbidity and mortality of diabetes patients as well as with markedly elevated direct and indirect costs for the health care system. In this article the most common skin diseases of patients with diabetes mellitus as well as their pathophysiology and current treatment are reviewed.
    Journal der Deutschen Dermatologischen Gesellschaft 10/2014; 12(10). · 1.40 Impact Factor
  • Revista Española de Geriatría y Gerontología 07/2014;